Monday, February 06, 2023 10:06:56 AM
UNCY 0.51 -MC $7 m- NDA filing for hyperphosphatemia treatment in mid 2023 , if approved the drug could reach $300+ million in annual revenue .
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
